Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [654]
News [1409]
Articles [231]
Editorials [9]
Conferences [81]
elearning [12]
Effectiveness of PARP inhibitors in ovarian cancer
Prof Jonathan Ledermann - University College London, UK
Effectiveness of PARP inhibitors in ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )
1 Nov 2012
Issues in sentinel node mapping in endometrial and vulva cancer
Prof Henry Kitchener – Manchester University, UK
Issues in sentinel node mapping in endometrial and vulva cancer ( Prof Henry Kitchener – Manchester University, UK )
31 Oct 2012
Complications in surgical approaches due to obesity
Dr Paola Gehrig – University of North Carolina, Chapel Hill, USA
Complications in surgical approaches due to obesity ( Dr Paola Gehrig – University of North Carolina, Chapel Hill, USA )
31 Oct 2012
Radical hysterectomy of cervical cancer
Dr Shingo Fujii – Kitano Hospital, Osaka, Japan
Radical hysterectomy of cervical cancer ( Dr Shingo Fujii – Kitano Hospital, Osaka, Japan )
31 Oct 2012
Retrospective study on adjuvant therapy in vulva cancer
Prof Sven Mahner - University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Retrospective study on adjuvant therapy in vulva cancer ( Prof Sven Mahner - University Medical Center Hamburg-Eppendorf, Hamburg, Germany )
31 Oct 2012
Phase III HECTOR study: recurring platinum sensitive ovarian cancer
Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg...
Phase III HECTOR study: recurring platinum sensitive ovarian cancer ( Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg, Germany )
31 Oct 2012
GOG 209 study: optimal management of advanced endometrial cancer
Prof David Miller – University of Texas Southwestern Medical Centre, Dallas, USA
GOG 209 study: optimal management of advanced endometrial cancer ( Prof David Miller – University of Texas Southwestern Medical Centre, Dallas, USA )
31 Oct 2012
AURELIA trial, palliative chemotherapy with bevacizumab in resistant, recurrent...
Dr Gunnar Kristensen – Norwegian Radium Hospital, Oslo, Norway
AURELIA trial, palliative chemotherapy with bevacizumab in resistant, recurrent ovarian cancer ( Dr Gunnar Kristensen – Norwegian Radium Hospital, Oslo, Norway )
30 Oct 2012
The Cancer Genome Atlas and high grade serous ovarian cancer
Dr Andrew Berchuck – Duke University Medical Center, Durham, USA
The Cancer Genome Atlas and high grade serous ovarian cancer ( Dr Andrew Berchuck – Duke University Medical Center, Durham, USA )
30 Oct 2012
Benefits of nomogram versus staging in cervical cancer
Dr Stephen Polterauer – Medical University of Vienna, Austria
Benefits of nomogram versus staging in cervical cancer ( Dr Stephen Polterauer – Medical University of Vienna, Austria )
30 Oct 2012
Gestational trophoblastic disease tumours in high risk patients
Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK
Gestational trophoblastic disease tumours in high risk patients ( Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK )
30 Oct 2012
Late effects of treatment in gynaecological cancers
Dr Remi Nout – Leiden University Medical Center, Netherlands
Late effects of treatment in gynaecological cancers ( Dr Remi Nout – Leiden University Medical Center, Netherlands )
30 Oct 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation